De Burlo Group’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-100
| Closed | -$1.91K | – | 148 |
|
|
2022
Q3 | $1.91K | Buy |
+100
| New | +$1.91K | ﹤0.01% | 180 |
|
|
2022
Q2 | – | Sell |
-100
| Closed | -$2.52K | – | 159 |
|
|
2022
Q1 | $2.52K | Buy |
+100
| New | +$2.52K | ﹤0.01% | 166 |
|
|
2014
Q4 | – | Sell |
-129,300
| Closed | -$4.99M | – | 114 |
|
|
2014
Q3 | $4.99M | Sell |
129,300
-250
| -0.2% | -$9.64K | 1.1% | 35 |
|
|
2014
Q2 | $5.04M | Buy |
129,550
+24,200
| +23% | +$942K | 1.14% | 37 |
|
|
2014
Q1 | $3.6M | Buy |
+105,350
| New | +$3.6M | 0.87% | 46 |
|